Savings that speak volumes: the economic benefits of perfusion bioprocessing

Recent advances in biopharmaceutical manufacturing technology have seen perfusion bioprocessing surge in popularity. In this article, Christopher Brau, R&D Process Development Manager at Thermo Fisher Scientific, examines this trend, highlighting its potential to enable cost-effective and highly productive processes.
Sponsored by
 
silverstream.tv

Latest news

28th September 2022

Emmes Acquires Clinical Edge

28th September 2022
As part of its strategy for global growth and the enhancement of internal expertise, focusing on biotech, Olon is delighted to present its two-year plan for investment in the Settimo Torinese Biotech Centre (Italy)
27th September 2022
Vectura’s £58m Inhalation Centre of Excellence Granted Planning Permission
27th September 2022
Pall Corporation Launches Three New Allegro™ Connect Systems – Delivering Greater Flexibility Through Configurability to Support Bioprocess Manufacturing
26th September 2022
WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility
26th September 2022
GSK picks Burberry's Brown as first female CFO
19th September 2022
Terumo Blood and Cell Technologies launches Quantum Flex bioreactor platform, one of the first systems that enables cell therapy commercialization from process development through manufacturing
16th September 2022
Olon appoints Roberta Pachera as Vice President of CDMO Small Molecules and Global Key Account Division
15th September 2022
Cytel expansion unlocks innovative clinical development expertise for APAC biopharma sector
13th September 2022
Stevanato Group and Gerresheimer AG Announce Collaboration on the Development of an Innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
13th September 2022
Takara Bio announces partnership for the distribution of CE-IVD solutions for respiratory tract infections
12th September 2022
Ayala Pharmaceuticals Presents Positive Interim Data from RINGSIDE Pivotal Phase 2/3 Trial of AL102 in Desmoid Tumors at ESMO Congress 2022
12th September 2022
Lonza Appoints Daniel Palmacci as President of the Cell & Gene Division
10th September 2022
WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility to Enhance Global CRDMO Services for Customers
8th September 2022
Merck Invests More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France
8th September 2022
Polyplus Builds on Research and Commercial mRNA Support Portfolio with in vivo-jetRNA®+ Transfection Reagent
7th September 2022
SIRIO enhances strategy for small and medium nutra innovators as Lonza’s Sara Lesina joins as GM in Europe
6th September 2022
Cytel expansion unlocks innovative clinical development expertise for APAC biopharma sector
6th September 2022
Catalent Expands Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
6th September 2022
"Genome Editing of Immune Cells" - New Lonza Virtual Event

This week’s featured articles

Why flexibility is essential when serving the pioneering CGT sector

Known as Cellular Orchestration Solutions, TrakCel systems are configured precisely to match the complex supply chain processes that are needed to provide cutting-edge medicines based on cell and gene therapies.

Life Sciences

Minaris Regenerative Medicine invests in new manufacturing facilities

European and Asian cell and gene therapy manufacturing capacity expansions complement new US commercial facility

Life Sciences

Sustainable API manufacture through continuous flow chemistry

Continuous manufacturing will enable the sustainable production of Active Pharmaceutical Ingredients.

Life Sciences

Trends and future challenges in inhaled drug delivery

Inhaled drug delivery offers many advantages for the treatment of many diseases, and its use is far wider than just for respiratory conditions.

Pharmaceuticals

Meeting the batch verification demands of cell & gene therapy manufacturing scale up

Cell & gene therapies (CGT) present an opportunity to fundamentally change the way diseases are treated. These personalized medicines present unique supply-chain and manufacturing challenges that differ from traditional pharmaceutical manufacturing of small molecules and biologics and new digital tools are required to support the scale up/out of CGT.

Life Sciences

Life Sciences Knowledge Hub

Stay up to date with industry news

Get the latest digital magazine and up to date news delivered right to your inbox.

Inside this issue
  • Biomanufacturing
  • Cancer Therapies
  • Bio International Convention 2022
  • Organic Process R&D Conference
  • Digitalization
  • Corporate Responsability


Previous Issues

Spotlight on Life Sciences

Find out more

Ethical Innovation Awards 2021

The Chemicals Knowledge Awards in partnership with CPhI North America celebrate ethical innovation throughout the Pharmaceutical industry. A lot of companies in the pharmaceutical industry are showing remarkable social responsibility, all the way from their drug manufacturing, through development and to delivery. At Chemicals Knowledge, we believe that those projects deserve to be recognised, celebrated and shared. That’s why Chemicals Knowledge is partnering with CPhI North America for the launch of the Ethical Innovation Awards - to bring together the best of the best in the pharmaceutical industry.

Find out more

Partnered with top industry events and organisations



logo
logo
logo
logo
logo